The Lancet Rheumatology

Contents

The Lancet Rheumatology is a peer-reviewed medical journal focusing on inflammatory and autoimmune diseases, translational research, and clinical trials in rheumatology. The journal is published by Elsevier under the The Lancet family and positions itself among specialty publications alongside The Lancet Oncology, The Lancet Neurology, The Lancet Infectious Diseases, and The Lancet Psychiatry. It aims to serve clinicians and researchers connected to institutions such as Royal College of Physicians, Mayo Clinic, Johns Hopkins University, Massachusetts General Hospital, and Harvard Medical School.

Overview

The Lancet Rheumatology covers a range of topics from basic immunology and musculoskeletal imaging to clinical trials and health policy, intersecting with research produced at National Institutes of Health, European Medicines Agency, Food and Drug Administration, World Health Organization, and specialty centers like Cleveland Clinic and Karolinska Institutet. Its readership includes physicians from American College of Rheumatology, researchers at Institut Pasteur, trainees from University of Oxford, and policymakers affiliated with National Health Service and investigators collaborating with consortia such as COMET Initiative and EULAR. The journal situates itself among comparable titles including Annals of the Rheumatic Diseases, Arthritis & Rheumatology, Rheumatology (Oxford), and Clinical Rheumatology.

Launched in 2019, the journal emerged during a period marked by high-profile publications from entities like Nature Medicine, Science Translational Medicine, and BMJ that emphasized translational and open science. Its establishment followed strategic expansion by Elsevier and editorial direction influenced by editors and advisors with affiliations to University College London, Stanford University School of Medicine, Imperial College London, and research groups collaborating with Wellcome Trust and Medical Research Council. Early editorial content responded to global events involving stakeholders such as COVID-19 pandemic, leading to special commissions mirroring editorial responses seen in The Lancet Infectious Diseases and The Lancet Global Health.

The journal publishes original research, reviews, meta-analyses, guidelines, and commentaries on conditions treated at centers like Mount Sinai Health System, UCSF Medical Center, Vanderbilt University Medical Center, and Toronto General Hospital. Topics include systemic lupus erythematosus research connected to investigators at University of Toronto, rheumatoid arthritis trials sponsored by pharmaceutical firms including Pfizer, Roche, AbbVie, and Novartis, as well as translational studies involving immunologists from Cold Spring Harbor Laboratory and geneticists from Broad Institute. Editorial pieces have engaged with guideline-producing bodies such as American College of Rheumatology and European League Against Rheumatism, and methodological discussions referencing standards from CONSORT, PRISMA, and collaborations with registries like ClinicalTrials.gov.

The Lancet Rheumatology is indexed in major databases and citation services akin to those used by journals indexed in PubMed, Scopus, Web of Science, and Embase. Its bibliometric footprint is tracked alongside metrics reported by organizations such as Clarivate Analytics and Elsevier Scopus, and it appears in institutional repositories used by University of Cambridge, Princeton University, and Yale University. Abstracting conventions follow norms established by indexing services used by titles cited in MEDLINE and aggregated by platforms connected to Google Scholar and CrossRef.

The journal’s articles have been cited by clinicians and researchers associated with Johns Hopkins Bloomberg School of Public Health, University of California, Los Angeles, King's College London, McGill University, and policy groups within European Commission and National Institutes of Health. Coverage of COVID-19–related rheumatological complications drew attention from specialty societies such as American College of Rheumatology and international collaborations like COVID-19 Global Rheumatology Alliance. Comparative impact and reputation are discussed in the context of legacy and newer titles such as Nature Reviews Rheumatology and The BMJ, with citation analyses performed by groups including Institute for Scientific Information and bibliometricians at Leiden University.

Published monthly by Elsevier within the The Lancet imprint, the journal follows peer-review procedures involving editorial boards with members from institutions like University of Pennsylvania, Columbia University, University of Edinburgh, and Monash University. The publication model balances subscription and open-access options, reflecting publishing trends debated at forums such as COPE, meetings convened by World Health Organization, and open science advocates associated with Wellcome Trust. Article processing charges, licensing, and access policies align with standards discussed at conferences organized by International Committee of Medical Journal Editors and consortia including Plan S.

Category:Medical journals